Blog

ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO

Photo taken from ACS Journal Cancer/X

May 24, 2024, 14:15

ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO

ACS Journal Cancer shared the following on X:

“Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at this year’s ASCO Plenary Session! ICYMI: Dr. Ramalingam and Ticiana Batista recently authored an editorial on the 20th anniversary of EGFR.”

Source: ACS Journal Cancer/X
>

ACS Journal Cancer ASCO Plenary Session cancer Cancer research cancer treatment clinical trial Editor-in-Chief editorial EGFR healthcare medical journal Medical Research OncoDaily Oncology phase 3 LAURA trial Research Suresh S. Ramalingam Ticiana Batista

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage